NCT02082496View on ClinicalTrials.gov

GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2019

Conditions
Obesity
Interventions
DRUG

Liraglutide

S.c. liraglutide 3.0mg once daily

Trial Locations (1)

2200

Department of Biomedical Sciences, Copenhagen

All Listed Sponsors
lead

University of Copenhagen

OTHER

NCT02082496 - GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations | Biotech Hunter | Biotech Hunter